Cytogenetics of the chronic myeloid leukemia-derived cell line K562 karyotype clarification by multicolor fluorescence in situ hybridization, comparative genomic hybridization, and locus-specific fluorescence in situ hybridization

Cancer Genetics and Cytogenetics

Volumn 118, Issue 1, 2000, Pages 1-8

  Gribble, Susan M ^a   Roberts, Ian ^a   Grace, Colin ^b   Andrews, Kathryn M ^c   Green, Anthony R ^a   Nacheva, Elizabeth P ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b Digital Scientific Ltd   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL LINE; CELL STRAIN K 562; CHROMOSOME 1; CHROMOSOME 12; CHROMOSOME 13; CHROMOSOME 18; CHROMOSOME 20; CHROMOSOME 20Q; CHROMOSOME 21; CHROMOSOME 6; CHROMOSOME 7; CHROMOSOME 9; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHRONIC MYELOID LEUKEMIA; COLOR; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCUS; HUMAN; HUMAN CELL; HYBRIDIZATION; KARYOTYPE; MARKER CHROMOSOME; PRIORITY JOURNAL; TECHNIQUE;

CHROMOSOME ABERRATIONS; CHROMOSOME BANDING; CHROMOSOME DELETION; CHROMOSOME PAINTING; COLOR; DNA PROBES; FEMALE; FLUORESCENT DYES; GENE AMPLIFICATION; GENETIC MARKERS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; K562 CELLS; KARYOTYPING; LEUKEMIA, MYELOID, CHRONIC; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; RECOMBINATION, GENETIC; SENSITIVITY AND SPECIFICITY; TRANSLOCATION, GENETIC;

EID: 0034176883     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(99)00169-7     Document Type: Article

References (39)

1. Rowley J.D. Letter. a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining Nature. 243:1973;290-293.
2. Heim S., Mitelman F. Cancer Cytogenetics. 1995;John Wiley & Sons, Inc, New York.
3. Lozzio C.B., Lozzio B.B. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood. 45:1975;321-333.
4. Klein E., Ben-Bassat H., Neumann H., Ralph P., Zeuthen J., Polliack A., Vanky F. Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia. Int J Cancer: 18:1976;421-431.
5. Ajmar F., Garre C., Sessarego M., Ravazzolo R., Barresi R., Scarra G.B., Lituania M. Expression of erythroid acetylcholinesterase in the K-562 leukemia cell line. Cancer Res. 43:1983;5560-5563.
6. Collins S.J., Groudine M.T. Rearrangement and amplification of c-abl sequences in the human chronic myelogenous leukemia cell line K-562. Proc Natl Acad Sci USA. 80:1983;4813-4817.
7. Selden J.R., Emanuel B.S., Wang E., Cannizzaro L., Palumbo A., Erikson J., Nowell P.C., Rovera G., Croce C.M. Amplified C lambda and c-abl genes are on the same marker chromosome in K562 leukemia cells. Proc Natl Acad Sci USA. 80:1983;7289-7292.
8. Chen T.R. Modal karyotype of human leukemia cell line, K562 (ATCC CCL 243). Cancer Genet Cytogenet. 17:1985;55-60.
9. Rodley P., McDonald M., Price B., Fright R., Morris C. Comparative genomic hybridization reveals previously undescribed amplifications and deletions in the chronic myeloid leukemia-derived K-562 cell line. Genes Chromosom Cancer. 19:1997;36-42.
10. Speicher M.R., Ballard S.G., Ward D.C. Karyotyping human chromosomes by combinatorial multi-fluor FISH. Nature Genet. 12:1996;368-375.
11. Schrock E., du Manoir S., Veldman T., Schoell B., Wienberg J., Ferguson Smith M.A., Ning Y., Ledbetter D.H., Bar Am I., Soenksen D., Garini Y., Ried T. Multicolor spectral karyotyping of human chromosomes. Science. 273:1996;494-497.
12. Veldman T., Vignon C., Schrock E., Rowley J., Ried T. Hidden chromosome abnormalities in haematological malignancies detected by multicolour spectral karyotyping. Nature Genet. 15:1997;406-410.
13. Rao P.H., Cigudosa J.C., Ning Y., Calasanz M.J., Lida S., Tagawa S., Michaeli J., Klein B., Dalla-Favera R., Jhanwar S.C., Ried T., Chaganti R.S.K. Multicolor spectral karyotyping identifies new recurring breakpoints and translocations in multiple myeloma. Blood. 92:1998;1743-1748.
14. Fleischman E.W., Reshmi S., Sokova O.I., Kirichenko O.P., Konstantino va L.N., Kulagina O.E., Frenkel M.A., Rowley J.D. Increased karyotype precision using fluorescence in situ hybridisation and spectral karyotyping in patients with myeloid malignancies. Cancer Genet Cytogenet. 108:1999;166-170.
15. Zattara-Cannoni H., Dufour H., Lepidi H., Chatel C., Grisoli F., Vagner-Capodano A.M. Hidden chromosome abnormalities in a primary central nervous system lymphoma detected by multicolor spectral karyotyping. Cancer Genet Cytogenet. 107:1998;98-101.
16. Marquez C., Cohen J., Munne S. Chromosome identification in human oocytes and polar bodies by spectral karyotyping. Cytogenet Cell Genet. 81:1998;254-258.
17. Nacheva E.P., Grace C.D., Bittner M., Ledbetter D.H., Jenkins R.B., Green A.R. Comparative genomic hybridisation. a comparison with molecular and cytogenetic analysis Cancer Genet Cytogenet. 100:1998;93-105.
18. Gribble S., Sinclair P., Grace C., Green A.R., Nacheva E. Comparative analysis of G-banding, chromosome painting, locus specific FISH and CGH in chronic myeloid leukaemia blast crisis. Cancer Genet Cytogenet. 111:1999;7-17.
19. Kallioniemi O.-P., Kallioniemi A., Piper J., Isola J., Waldman F.M., Gray J.W., Pinkel D. Optimizing comparative genomic hybridisation for analysis of DNA sequence copy number changes in solid tumours. Genes Chromosom Cancer. 10:1994;231-243.
20. du Manoir S., Kallioniemi O.P., Lichter P., Piper J., Benedetti P.A., Carothers A.D., Fantes J.A., Garcia Sagredo J.M., Gerdes T., Giollant M. Hardware and software requirements for quantitative analysis of comparative genomic hybridization. Cytometry. 19:1995;4-9.
21. Roberts I., Wienberg J., Nacheva E., Grace C., Griffin G., Coleman N. A novel method for the production of multiple colour chromosome paints for use in karyotyping by fluorescence in situ hybridisation. Genes Chromosom Cancer. 25:1999;230-240.
22. Wu S.Q., Voelkerding K.V., Sabatini L., Chen X.R., Huang J., Meisner L.F. Extensive amplification of bcr/abl fusion genes clustered on three marker chromosomes in human leukemic cell line K-562. Leukemia. 9:1995;858-862.
23. Begley C.G., Aplan P.D., Davey M.P., Nakahara K., Tchorz K., Kurtzberg J., Hersfield M.S., Haynes B.F., Cohen D.I., Waldmann T.A., Kirsch I.R. Chromosomal translocation in a human leukemic stem-cell line disrupts the T-cell antigen receptor delta-chain diversity region and results in a previously unreported fusion transcript. Proc Natl Acad Sci USA. 86:1989;2031-2035.
24. Green A.R., Begley C.G. SCL and related hemopoietic helix-loop-helix transcription factors. Int J Cell Cloning. 10:1992;269-276.
25. Bakhshi A., Jensen J.P., Goldman P., Wright J.J., McBride O.W., Epstein A.L., Korsmeyer S.J. Cloning the chromosomal breakpoint of t(14;18) human lymphomas. clustering around JH on chromosome 14 and near a translocation unit on 18 Cell. 41:1985;899-906.
26. Knutsen T. Cytogenetic mechanisms in the pathogenesis and progression of follicular lymphoma. Cancer Surv. 30:1997;163-192.
27. Oltvai Z.N., Milliman C.L., Korsmeyer S.J. Bcl-2 heterodimerises in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 74:1993;609-619.
28. Nourse J., Mellentin J.D., Galili N., Wilkinson J., Stanbridge E., Smith S.D., Cleary M.L. Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor. Cell. 60:1990;535-545.
29. Kamps M.P., Murre C., Sun X.H., Baltimore D. A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL. Cell. 60:1990;547-555.
30. Aplan P.D., Johnson B.E., Russell E., Chervinsky D.S., Kirsch I.R. Cloning and characterisation of TCTA, a gene located at the site of a t(1;3) translocation. Cancer Res. 55:1995;1917-1921.
31. Yokoyama Y., Ohsugi K., Kozaki T., Sakuragawa N. Microdissection-mediated selection of chromosome region-specific cDNAs. Cytogenet Cell Genet. 77:1997;192-196.
32. Guan X.Y., Meltzer P.S., Dalton W.S., Trent J.M. Identification of cryptic sites of DNA sequence amplification in human breast cancer by chromosome microdissection. Nature Genet. 8:1994;155-160.
33. Parente F., Gaudray P., Carle G.F., Turc-Carel C. Experimental assessment of the detection limit of genomic amplification by comparative genomic hybridisation CGH. Cytogenet Cell Genet. 78:1997;65-68.
34. Sill H., Goldman J.M., Cross N.C. Homozygous deletions of the p16 tumor-suppressor gene are associated with lymphoid transformation of chronic myeloid leukemia. Blood. 85:1995;2013-2016.
35. Guinn B.A., Mills K.I. p53 mutations, methylation and genomic instability in the progression of chronic myeloid leukaemia. Leuk Lymphoma. 26:1997;211-226.
36. Stuppia L., Calabrese G., Peila R., Guanciali Franchi P., Morizio E., Spadano A., Palka G. p53 loss and point mutations are associated with suppression of apoptosis and progression of CML into myeloid blastic crisis. Cancer Genet Cytogenet. 98:1997;28-35.
37. Nakai H., Misawa S. Chromosome 17 abnormalities and inactivation of the p53 gene in chronic myeloid leukemia and their prognostic significance. Leuk Lymphoma. 19:1995;213-221.
38. Asimakopoulos F.A., Green A.R. Deletions of chromosome 20q and the pathogenesis of myeloproliferative disorders. Br J Haematol. 95:1996;219-226.
39. Mori N., Morosetti R., Lee S., Spira S., Ben Yehuda D., Schiller G., Landolfi R., Mizoguchi H., Koeffler H.P. Allelotype analysis in the evolution of chronic myelocytic leukemia. Blood. 90:1997;2010-2014.